Carotid artery revascularization with distal protection in high-surgical-risk patients in routine clinical practice: Rationale and design of the CABANA safety surveillance program

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 1, 2012, Pages 167-173

  White, Christopher J ^a   Avula, Surendra B ^b   Mintz, Randy T ^c   Iskander, Ayman ^d   Chervu, Arun ^e   Feldman, Robert L ^f   Schermerhorn, Marc L ^g   Woo, Henry H ^h   Hopkins, L Nelson ⁱ  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

^b ADVOCATE CHRIST MEDICAL CENTER   (United States)

^c OUR LADY OF LOURDES MEDICAL CENTER   (United States)

^d ST JOSEPH S HOSPITAL HEALTH CENTER   (United States)

^e WellStar Health Systems   (United States)

^f Munroe Regional Med Center   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY AT BUFFALO   (United States)

Author keywords

carotid artery; carotid stenosis; stent; stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CLINICAL EVALUATION; CLINICAL PRACTICE; EMBOLIC PROTECTION DEVICE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; MORTALITY; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PATIENT SAFETY; PROSPECTIVE STUDY; STENT THROMBOSIS; STROKE; TREATMENT OUTCOME;

EID: 84255187267     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23257     Document Type: Article

References (20)

1. Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med 2008; 358: 1572-1579. (Pubitemid 351519817)
2. Brott TG, Hobson RW II, Howard G, Roubin GS, Clark WM, et al. Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis. N Engl J Med 2010; 363: 11-23.
3. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. A guideline for healthcare professionals from the american heart association/american stroke association. Stroke, in press. doi: 10.1161/STR. 0b013e3181f7d043.
4. White CJ, Iyer SS, Hopkins LN, Katzen BT, Russell ME,. Carotid stenting with distal protection in high surgical risk patients: The BEACH trial 30 day results. Catheter Cardiovasc Interv 2006; 67: 503-512.
5. Iyer SS, White CJ, Hopkins LN, Katzen BT, Safian R, et al. Carotid artery revascularization in high-surgical-risk patients using the Carotid WALLSTENT and FilterWire EX/EZ: 1-year outcomes in the BEACH Pivotal Group. J Am Coll Cardiol 2008; 51: 427-434.
6. Gray WA, Hopkins LN, Yadav S, Davis T, Wholey M, et al. Protected carotid stenting in high-surgical-risk patients: The ARCHeR results. J Vasc Surg 2006; 44: 258-268. (Pubitemid 44142925)
7. Gray WA, Yadav JS, Verta P, Scicli A, Fairman R, et al. The CAPTURE registry: Predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv 2007; 70: 1025-1033.
8. Safian RD, Bresnahan JF, Jaff MR, Foster M, Bacharach JM, Maini B, Turco M, Myla S, Eles G, Ansel GM,. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol 2006; 47: 2384-2389. (Pubitemid 43866375)
9. Hopkins LN, Myla SV, Grube E, Eles G, Dave R, Jaff MR, Allocco DJ,. Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial. EuroIntervention 2010; 5: 917-924.
10. Katzen BT, Criado FJ, Ramee SR, Massop DW, Hopkins LN, Donohoe D, Cohen SA, Mauri L,. Carotid artery stenting with emboli protection surveillance study: Thirty-day results of the CASES-PMS study. Catheter Cardiovasc Interv 2007; 70: 316-323. (Pubitemid 47206049)
11. Meier P, Knapp G, Tamhane U, Chaturvedi S, Gurm HS,. Short term and intermediate term comparison of endarterectomy versus stenting for carotid artery stenosis: Systematic review and meta-analysis of randomised controlled clinical trials BMJ 2010; 340: c467.
12. Zeebregts CJ, Meerwaldt R, Geelkerken RH,. Carotid artery stenting: A 2009 update. Curr Opin Cardiol 2009; 24: 528-531.
13. Ringleb PA, Allenberg J, Bruckmann H, Eckstein HH, Fraedrich G, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial. Lancet 2006; 368: 1239-1247.
14. Sidawy AN, Zwolak RM, White RA, Siami FS, Schermerhorn ML, Sicard GA,. Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: Results from the SVS vascular registry. J Vasc Surg 2009; 49: 71-79.
15. Gray WA, Chaturvedi S, Verta P,. Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high-surgical-risk registries. Circ Cardiovasc Interv 2009; 2: 159-166.
16. Massop D, Dave R, Metzger C, Bachinsky W, Solis M, Shah R, Schultz G, Schreiber T, Ashchi M, Hibbard R,. Stenting and angioplasty with protection in patients at high-risk for endarterectomy: SAPPHIRE Worldwide Registry first 2,001 patients. Catheter Cardiovasc Interv 2009; 73: 129-136.
17. Myla S, Bacharach JM, Ansel GM, Dippel EJ, McCormick DJ, Popma JJ,. Carotid artery stenting in high surgical risk patients using the FiberNet embolic protection system: The EPIC trial results. Catheter Cardiovasc Interv 2010; 75: 817-822.
18. Biller J, Feinberg WM, Castaldo JE, Whittemore AD, Harbaugh RE, et al. Guidelines for carotid endarterectomy: A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1998; 97: 501-509. (Pubitemid 28090224)
19. NIH. 2008. NIH Stroke Scale. Volume 2009.
20. Centers for Medicare and Medicaid Services (CMS). 2007. Pub 100-03 Medicare National Coverage Determinations, Subject: Percutaneous Transluminal Angioplasty.